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Insulin and growth factors activate the phosphatidylinositide-
3-kinase pathway, leading to stimulation of several kinases
including serum- and glucocorticoid-inducible kinase isoform
SGK3, a transport regulating kinase. Here, we explored
the contribution of SGK3 to the regulation of renal
tubular phosphate transport. Coexpression of SGK3 and
sodium-phosphate cotransporter IIa significantly enhanced
the phosphate-induced current in Xenopus oocytes. In sgk3
knockout and wild-type mice on a standard diet, fluid intake,
glomerular filtration and urine flow rates, and urinary calcium
ion excretion were similar. However, fractional urinary
phosphate excretion was slightly but significantly larger in
the knockout than in wild-type mice. Plasma calcium ion,
phosphate concentration, and plasma parathyroid hormone
levels were not significantly different between the two
genotypes, but plasma calcitriol and fibroblast growth
factor 23 concentrations were significantly lower in the
knockout than in wild-type mice. Moreover, bone density was
significantly lower in the knockouts than in wild-type mice.
Histological analysis of the femur did not show any
differences in cortical bone but there was slightly less
prominent trabecular bone in sgk3 knockout mice. Thus,
SGK3 has a subtle but significant role in the regulation of
renal tubular phosphate transport and bone density.
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Phosphate is a critically important component of bone
minerals.1,2 Accordingly, adequate mineralization of bone
depends on the precise tuning of phosphate balance, which is
a function of intestinal absorption and renal excretion.1,3,4
The latter depends on cellular uptake of phosphate across the
apical membrane of proximal tubular cells,5 which is mainly
accomplished by the Naþ -coupled phosphate transporter
NaPiIIa.3,5 The carrier is downregulated by parathyroid
hormone (PTH),3 a hormone at least in part effective
through cyclic adenosine monophosphate. In contrast, renal
tubular phosphate reabsorption is stimulated by insulin6,7
and insulin-like growth factor IGF1.8,9 Little is known,
however, about the signaling involved in the insulin- and
IGF1-mediated regulation of phosphate excretion.
The signaling of insulin involves the serum- and
glucocorticoid-inducible kinase SGK3,10 which, similar to
protein kinase B11 and SGK1,12 is activated by phosphatidy-
linositol-3-kinase and phosphoinositide-dependent kinase
PDK1. SGK3 is known to regulate a wide variety of transport
systems.13
The present study thus explored the possibility that SGK3
may be involved in the regulation of renal tubular transport.
To this end, the in vitro regulation of NaPiIIa by SGK3 was
studied in the heterologous Xenopus oocyte expression
system and in vivo significance of SGK3-sensitive phosphate
transport elucidated by analyzing gene-targeted mice lacking
functional SGK3 (sgk3KO) as well as wild-type mice
(sgk3WT).14
RESULTS
A first series of experiments analyzed the in vitro influence of
the serum- and glucocorticoid-inducible kinase isoform
SGK3 on NaPiIIa, the major renal tubular phosphate
transporter. Exposure of non-injected Xenopus oocytes to
phosphate (3mmol/l) in the bath solution did not induce a
significant current, indicating that these oocytes do not
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express significant endogenous electrogenic phosphate trans-
port (Figure 1a). In oocytes injected with complementary
RNA encoding NaPiIIa, however, the addition of phosphate
(3mmol/l) induced an inward current (IPi; Figure 1a).
Coexpression of SGK3 significantly increased IPi in NaPiIIa-
expressing oocytes (Figure 1a). Expression of SGK3 alone did
not induce IPi, indicating that SGK3 was indeed effective by
stimulating NaPiIIa. The membrane abundance of NaPiIIa in
oocytes was determined by a chemiluminiscence-based assay.
As shown in Figure 1b, coexpression of SGK3 significantly
increased the surface expression of NaPiIIa to a similar extent
as it stimulated phosphate-induced currents.
Experiments in brush border membrane vesicle (BBMV)
preparations from sgk3KO and sgk3WT mice were performed
to determine the sodium-dependent transport of phosphate
ex vivo. However, no significant difference in total and
phosphonoformic acid (6mmol/l)-resistant transport was
observed between sgk3KO and sgk3WT mice (Figure 2).
Similarly, the protein expression of the phosphate transpor-
ters NaPiIIa, NaPiIIc, and Pit2 in brush border membrane
fractions was not different between the genotypes (Figure 2).
The transcript levels of these transporters were similarly not
significantly different between sgk3KO and sgk3WT mice (data
not shown).
A further series of experiments explored whether SGK3
participates in the regulation of renal phosphate excretion
in vivo. To this end, metabolic cage experiments were
performed in sgk3KO and sgk3WT mice. As shown in Table 1,
the body weight was similar in sgk3KO mice and sgk3WTmice.
Fluid intake tended to be slightly higher in sgk3KO than in
sgk3WT mice, a difference, however, not reaching statistical
significance (Table 1). Food intake was slightly but sig-
nificantly higher in sgk3KO than in sgk3WT mice (Table 1).
No significant differences between the genotypes were
observed in the plasma Ca2þ and phosphate concentration
(Table 1, Figure 3). Similarly, the plasma glucose concentra-
tion was not significantly different between genotypes (data
not shown).
The urinary flow rate and creatinine clearance tended to
be slightly higher in sgk3KO mice than in sgk3WT mice, a
difference, however, not reaching statistical significance
(Table 1). The absolute (Table 1) and fractional (Figure 3)
excretions of Ca2þ were not significantly different between
the two genotypes. In contrast, the absolute (Table 1) and
fractional (Figure 3) excretions of phosphate were signifi-
cantly higher in sgk3KO mice than in sgk3WTmice. In neither
the sgk3WT nor the sgk3KO mice, glucosuria was observed
(data not shown).
The renal phosphate excretion was further studied under a
low-phosphate diet. The urinary phosphate excretion was still
significantly higher in sgk3KO (0.17±0.03 mmol/24 h per g
body weight; n¼ 5) than in sgk3WT (0.10±0.01 mmol/24 h
per g body weight; n¼ 6) mice. To further analyze the renal
function of those mice, acute inulin clearance studies were
performed under anesthesia. The glomerular filtration rate
(GFR) as determined from the inulin clearance was not
significantly different between sgk3WT (119±28 ml/min;
n¼ 5) and sgk3KO (92±22 ml/min; n¼ 5) mice. In this series,
the fractional excretion of phosphate was again higher in
sgk3KO (2.4±0.3%) than in sgk3WT (1.7±0.1%) mice.
The phosphaturia could have been secondary to altered
levels of hormones involved in phosphate homeostasis.
Therefore, the plasma levels of PTH, calcitriol
(1,25(OH)2D3) and fibroblast growth factor 23 (FGF 23)
were determined. As illustrated in Figure 4, the PTH plasma
concentration was not significantly different between the
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Figure 1 |Coexpression of SGK3 stimulates electrogenic phosphate transport in NaPiIIa-expressing Xenopus oocytes. (a) Arithmetic
means±s.e.m. (n¼ 11–18) of phosphate (3mmol/l)-induced currents (IPi) in Xenopus oocytes injected with water (H2O) or complementary
RNA (cRNA) encoding SGK3 or NaPiIIa, or cRNA encoding both SGK3 and NaPiIIa. *Indicates significant difference from absence of cRNA
encoding NaPiIIa (po0.05). ###Indicates significant difference from absence of cRNA encoding SGK3 (Po0.001). (b) Arithmetic
means±s.e.m. (n¼ 42–60) of the normalized chemiluminescence intensity of NaPiIIa expression in Xenopus oocytes injected with H2O (left
bar), with cRNA encoding (middle bar), or with cRNA encoding both, NaPiIIa and SGK3 (right bar). *Indicates statistically significant
difference from absence of cRNA (Po0.05). ###Indicates difference from absence of SGK3 cRNA (Po0.001). RLU, relative luminescence.
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genotypes, whereas the plasma 1,25(OH)2D3 and plasma
FGF23 concentrations were significantly lower in sgk3KO mice
compared with sgk3WT mice.
The renal loss of phosphate is expected to foster
demineralization of bone. Thus, the bone density was
determined in sgk3KO and sgk3WT mice. As shown in
Figure 5a, the bone density was indeed lower in sgk3KO than
in sgk3WT mice. A histological analysis of the femur showed
no obvious differences in the cortical bone between the two
genotypes but revealed that the trabecular bone appeared
to be less prominent in sgk3KO mice than in sgk3WT mice
(Figure 5b).
DISCUSSION
The present observations disclose a novel function of SGK3,
that is, stimulation of renal tubular phosphate transport.
According to the experiments on Xenopus oocytes, coexpres-
sion of SGK3 increases NaPiIIa activity. The in vivo relevance
of SGK3-sensitive NaPiIIa regulation is underscored by the
mild phosphaturia of sgk3KO mice.
The phosphaturia of sgk3KO mice was not due to an
increased plasma phosphate concentration and occurs with-
out significant alterations of the PTH plasma concentration.
The hormone is well known to downregulate renal phosphate
transport,3 and its release is stimulated by an enhanced
plasma phosphate concentration.15 The plasma levels of
1,25(OH)2D3 were significantly decreased in sgk3
KO mice.
The rate-limiting enzyme in the generation of 1,25(OH)2D3
is the renal 1a-hydroxylase,16,17 which is stimulated by PTH17
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Figure 2 |Protein abundance of renal sodium-dependent phosphate cotransporters and sodium-dependent phosphate transport
activity in brush border membrane vesicles (BBMVs) of SGK3 knockout mice (sgk3KO) and wild-type mice (sgk3WT) mice.
(a) Original western blots for NaPiIIa, NaPiIIc, and Pit2. All membranes were stripped and reprobed for b-actin to control for loading.
(b) Arithmetic means±s.e.m. (n¼ 5–6 each group) of the sodium-dependent transport rates into isolated BBMVs after 1min in the absence
(upper bars) and presence (lower bars) of 6mmol/l phosphonoformic acid (PFA) to block phosphate transport mediated by SLC34 family
members. (c) Arithmetic means±s.e.m. (n¼ 6 each group) of relative band density of NaPilla (left panel), NaPillc (middle panel), and
Pit2 (right panel).
Table 1 | Analysis of blood and urine of sgk3KO and sgk3WT
mice
sgk3WT sgk3KO
BW (g) 23.8±0.6 23.6±0.6
Food intake (mg/g BW) 187±7 207±6*
Fluid intake (mg/g BW) 275±15 304±16
[Ca2+]plasma (mg/dl) 9.31±0.08 9.33±0.11
[Pi]plasma (mg/dl) 7.04±0.21 7.18±0.22
Urine Ca2+ (mmol/24 h per g BW) 0.30±0.02 0.31±0.03
Urine Pi (mmol/24 h per g BW) 0.50±0.12 0.97±0.18
*
Urinary flow rate (ml/24 h per g BW) 48.5±6.3 61.1±5.7
Creatinine clearance (ml/min per g BW) 4.8±0.6 6.1±0.9
Fractional renal Ca2+ excretion (%) 1.9±0.2 1.8±0.1
Fractional renal Pi excretion (%) 4.6±0.9 7.6±1.4
*
Abbreviations: BW, body weight; Pi, inorganic phosphate; sgk3
KO, SGK3 knockout
mice; sgk3WT, wild-type mice.
BW, food and fluid intake, plasma concentration and renal excretion of Ca2+ and
phosphate, urinary flow rate, creatinine clearance, and fractional renal excretion of
Ca2+ and phosphate in sgk3KO and sgk3WT mice. Arithmetic means±s.e.m. (n=10–19
mice); *indicates significant difference between genotypes (Po0.05).
Kidney International (2011) 80, 61–67 63
M Bhandaru et al.: SGK3-sensitive phosphate excretion o r ig ina l a r t i c l e
and cellular phosphate depletion.18 A decreased NaPiIIa
activity is expected to decrease the entry of phosphate into
proximal tubule cells and thus to rather decrease the
phosphate concentration in proximal tubular cells. A
decreased cellular phosphate concentration is in turn
expected to increase the 1,25(OH)2D3 formation. Possibly,
SGK3 participates in the regulation of 1,25(OH)2D3 forma-
tion, which has previously been shown to be stimulated by
IGF1.19 As 1,25(OH)2D3 stimulates renal tubular phosphate
transport,20 decreased 1,25(OH)2D3 formation could con-
tribute to the phosphaturia of sgk3KO mice. Moreover,
1,25(OH)2D3 is a powerful stimulator of intestinal phosphate
transport.21 It is, however, not required for the adaptive
increase in intestinal phosphate absorption in dietary
phosphate depletion.22 The decrease of 1,25(OH)2D3
plasma levels may account for the decreased formation of
FGF23, which should rather disinhibit 1a-hydroxylase and
should thus increase 1,25(OH)2D3 concentrations. The
decreased FGF23 levels were expected to counteract renal
phosphate losses.
We did not observe a significant decrease of the plasma
phosphate concentration despite the mild phosphaturia.
Enhanced phosphate excretion must thus be paralleled by
enhanced intestinal phosphate absorption or phosphate loss
from bone. In an earlier study, fecal phosphate excretion was
not significantly different between SGK3KO and sgk3WT
mice.23 However, the food intake was significantly higher in
sgk3KO mice than in sgk3WT mice, and thus intestinal
phosphate absorption might indeed have been increased.
The phosphaturia of sgk3KO mice was not paralleled by a
decrease of phosphate transport across BBMVs or of mRNA
and protein abundance of the phosphate transporters. The
lack of significant differences between tissue of sgk3WT mice
and sgk3KO mice is at seeming contrast to the powerful effect
of SGK3 on NaPiIIa expression in Xenopus oocytes. It must
be kept in mind, although, that the in vivo effect of SGK3 is
paralleled by a similar effect of PKB/Akt,24 and thus knockout
of one of the kinases in mice does not abrogate SGK3/PKB/
AKT-dependent regulation of NaPiIIa and is thus not
expected to yield similarly strong effects as overexpression
of SGK3 in Xenopus oocytes. The mild phosphaturia of
sgk3KO mice confirms that SGK3 indeed participates in the
regulation of renal tubular phosphate reabsorption. It
remains elusive, although, why the phosphaturia is not
reflected by respective alterations of carrier protein abun-
dance and phosphate uptake in brush border vesicles.
Possibly, SGK3 does not only affect NaPiIIa abundance in a
heterologous expression system such as oocytes, but may also
stimulate the activity of phosphate transporter in vivo
without altering their cell surface expression.
The sgk3KO mice suffer from a subtle but significant
decrease of bone mass, which may again be partially due to
decreased formation of 1,25(OH)2D3. The 1,25(OH)2D3 is
known to counteract apoptosis of osteoblasts25 and thus
enhances bone mineralization.26 The effect of 1,25(OH)2D3
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Figure 3 | Fractional excretion of calcium and phosphate in
SGK3 knockout mice (sgk3KO) and wild-type mice (sgk3WT).
(a) Arithmetic means±s.e.m. (n¼ 10–19 each group) of plasma
calcium (left panel) and phosphate (right panel) concentration in
sgk3KO (closed bars) and sgk3WT (open bars) mice. (b) Arithmetic
means±s.e.m. (n¼ 10–19 each group) of fractional urinary
calcium (left panel) and phosphate (right panel) excretion in
sgk3KO (closed bars) and sgk3WT (open bars) mice. *Po0.05
versus respective value of sgk3WT mice. FE, fractional excretion.
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Figure 4 |Plasma parathyroid hormone (PTH), FGF23, and calcitriol (1,25(OH)2D3) concentrations in SGK3 knockout mice (sgk3
KO)
and wild-type mice (sgk3WT). Arithmetic means±s.e.m. of plasma PTH (a; n¼ 10 each group), 1,25(OH)2D3 (b; n¼ 10–12 each group),
and FGF23 (c; n¼ 8 in each group) concentration in sgk3KO (closed bars) and sgk3WT (open bars) mice. *Po0.05 versus respective value
of sgk3WT mice.
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in osteoblasts is mediated by the phosphoinositide-3-kinase
pathway,27 and may thus involve at least partially SGK3. The
demineralization of bone may further be due to phosphate
depletion, as phosphate inhibits the formation of new
osteoclasts and stimulates apoptosis of mature osteoclasts.28
The present observations do not rule out the participation of
further mechanisms. For instance, SGK3 shares several
functions with Akt2/PKBb,29 which has been shown to
confer survival of osteoblasts30 and osteoclasts.31,32
In conclusion, the present observations reveal a novel
function of SGK3, that is, its involvement in the regulation of
1,25(OH)2D3 plasma concentration, renal phosphate excre-
tion, and mineralization of bone.
MATERIALS AND METHODS
In vitro experiments
For generation of complementary RNA, constructs were used
encoding wild-type human NaPiIIa33 and human SGK3.10 The
complementary RNA was generated as described previously.34 SGK3
cDNA was kindly provided by Sir Philip Cohen (MRC Protein
Phosphorylation Unit, Dundee) and the cDNA encoding NaPiIIa by
Heini Murer, (University of Zurich, Zurich). For electrophysiology,
Xenopus oocytes were prepared as previously described.35,36 Wild-
type SGK3 (7.5 ng) and 15 ng of NaPiIIa complementary RNA were
injected on the same day after preparation of Xenopus oocytes. All
experiments were performed at room temperature 4–5 days after
injection. Two electrode voltage-clamp recordings were performed
at a holding potential of 50mV.37 The data were filtered at 10Hz
and recorded with a Digidata A/D-D/A converter and Chart V.4.2
software for data acquisition and analysis (Axon Instruments, Berlin,
Germany).38 The control solution (superfusate/ND96) contained
96mmol/l NaCl, 2mmol/l KCl, 1.8mmol/l CaCl2, 1mmol/l MgCl2,
and 5mmol/l HEPES, pH 7.4. Phosphate (2mmol/l) was added to
induce NaPiIIa-dependent currents. The flow rate of the superfusion
was 20ml/min, and a complete exchange of the bath solution was
reached within about 10 s. All experiments were repeated with at
least three batches of oocytes; in all repetitions, qualitatively similar
data were obtained.
Detection of NaPiIIa cell surface expression by
chemiluminescence
Defolliculated oocytes were incubated with primary rabbit anti-
NaPiIIa antibody (diluted 1:500, Lifespan Biosciences, Seattle, WA)
and secondary, peroxidase-conjugated goat anti-rabbit antibody
(diluted 1:1000, Cell Signaling, Danvers, MA). Individual oocytes
were placed in 96-well plates with 10 ml of Super Signal ELISA Femto
Maximum Sensitivity Substrate (Pierce, Rockford, IL). Chemilumi-
nescence of single oocytes was quantified in a luminometer
(WalterWallac2 plate reader, Perkin Elmer, Ju¨gesheim, Germany)
by integrating the signal over a period of 1 s. Results display
normalized arbitrary light units that are proportional to the detector
voltage.
In vivo function
All animal experiments were conducted according to the German
law for the welfare of animals and were approved by local
authorities.
Generation and basic properties of the SGK3 knockout mice
(sgk3KO) were described previously.39 The mice were compared with
the wild-type mice (sgk3WT) and genotyped by PCR on tail DNA
using SGK3- and neoR-specific primers as previously described.39
The mice (age 3.5–6 months) were fed a control diet containing
0.7% phosphate (C1314, Altromin, Lage, Germany) or 7-day-low-
phosphate diet containing less than 0.1% phosphate (C 1048
Altromin, Germany) with free access to tap drinking water.
For evaluation of renal excretion, both sgk3KO and sgk3WT mice
were placed individually in metabolic cages (Techniplast, Hohen-
peissenberg, Germany) for 24-h urine collection, as described
previously.40 They were allowed a 3-day habituation period during
which food and water intake, urinary flow rate, urinary excretion of
salt, fecal excretion, and body weight were recorded every day to
ascertain that the mice were adapted to the new environment.
Subsequently, 24-h collection of urine was performed for several
consecutive days to obtain the urinary parameters. To assure
quantitative urine collection, metabolic cages were siliconized, and
urine was collected under water-saturated oil.
To obtain blood specimens, animals were lightly anesthetized
with diethylether (Roth, Karlsruhe, Germany), and about 150ml of
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Figure 5 |Bone density and histological analysis of femur bones from SGK3 knockout mice (sgk3KO) and wild-type mice (sgk3WT).
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blood was withdrawn into heparinized capillaries by puncturing the
retro-orbital plexus.
Urinary phosphate concentration was determined colorimetri-
cally utilizing a commercial diagnostic kit (Roche Diagnostics,
Mannheim, Germany). Plasma and urinary calcium, and plasma
phosphate concentration were determined by a photometric method
according to the manufacturer’s instructions (dri-chem clinical
chemistry analyzer FUJI FDC 3500i, Sysmex, Norsted, Germany).
Creatinine concentration in urine was determined using the Jaffe
reaction (Sigma, St Louis, MO), creatinine concentration in serum
was measured using an enzymatic kit (creatinine PAP, Lehmann,
Berlin, Germany) according to the manufacturer’s instructions.
Plasma PTH concentration was measured using an ELISA kit
(Immunotopics, San Clemente, CA). A radioimmunoassay kit was
employed to determine the concentration of 1,25(OH)2-vitamin D3
(IDS, Boldon, UK) in plasma. Plasma FGF23 was determined using
an ELISA kit (Immunotopics, San Clemente, CA).
Clearance experiments
Clearance experiments were performed in anaesthetized SGK3 wild-
type and knockout mice (n¼ 5 in each group), as described
previously.41,42 Briefly, mice were anesthetized intraperitoneally with
80mg/kg sodium pentobarbital. Body temperature was maintained
at 37.5 1C by placing the animals on an operating table with a servo-
controlled heating plate. The trachea was cannulated for free air
breathing throughout the experiment. The left femoral artery was
cannulated for arterial blood pressure recording and blood sample
withdrawal. The right jugular vein was cannulated for continuous
maintenance infusion of 0.85% NaCl at a rate of 8 ml/min. For
assessment of GFR, [3H]-inulin was added into 0.85% NaCl
solution to deliver 20 mCi/h radioactive inulin. Urine samples were
collected via a catheter inserted into the urinary bladder. After
surgical preparation, mice were allowed to stabilize for 20min.
Subsequently, to determine renal function, a 60-min urine collection
period was performed. Blood samples (80 ml) were collected
immediately before and after urine collections. Blood pressure was
recorded before every blood sample collection. Urinary flow rate was
determined gravimetrically. Concentrations of [3H]inulin in plasma
and urine were measured by liquid-phase scintillation counting. The
glomerular filtration rate was calculated according to standard
formulas.
Brush border membrane preparation and phosphate
transport assays
BBMVs were prepared from mice kidney cortex and outer medulla
using the Mg2þ precipitation technique, as described previously.43
The phosphate transport rate into BBMVs was measured in freshly
prepared BBMV at 25 1C in the presence of inward gradients of
100mmol/l NaCl or 100mmol/l KCl and 0.1mmol/l K phosphate.
The substrate inorganic phosphate was made with 0.125mmol/l
K2HPO4 and
32P (1mCi/ml) to yield a final concentration 0.1mmol/
l close to the expected apparent KmPi for Naþ -dependent transport
in renal BBMVs. The stop solution contained 100mmol/l mannitol,
5mmol/l Tris-HCl, pH 7.4, 150mmol/l NaCl, and 5mmol/l
inorganic phosphate. Naþ dependence was established by incubat-
ing BBMVs in solutions in which KCl replaced NaCl equimolarly.
Phosphate uptake was determined after 60 s, representing initial
linear conditions, and after 120min, to determine the equilibrium
values. To distinguish between Naþ -dependent inorganic phosphate
uptake mediated by SLC34 family members (for example, NaPiIIa
and NaPiIIc) and other Naþ -dependent phosphate transporters,
such as SLC20 family members (for example, Pit1 and Pit2),
trisodium phosphonoformic acid (final concentration 6mmol/l)
added to the same solution with 107mmol/l NaCl was used.
Phosphonoformic acid has previously been shown to have a higher
selectivity for SLC34 than SLC20 phosphate transporters at this
concentration.44 The total protein concentration was measured
using the Bio-Rad Protein Assay kit; Bio-Rad, Hercules, CA. BBMVs
were stored at 80 1C until further use.
Western blotting
After measurement of the protein concentration (Bio-Rad), 10 mg of
renal brush border membrane proteins was solubilized in loading
buffer containing dithiothreitol and separated on 8% polyacryla-
mide gels. For immunoblotting, the proteins were transferred
electrophoretically to polyvinylidene fluoride membranes (Immo-
bilon-P, Millipore, Bedford, MA). After blocking with 5% milk
powder in Tris-buffered saline/0.1% Tween-20 for 60min, the blots
were incubated with the primary antibodies: rabbit polyclonal anti-
NaPiIIa (1:6000)45 rabbit polyclonal anti-NaPiIIc (1:10,000),46
rabbit polyclonal anti-Pit2 (1:3000; kindly provided by Dr V
Sorribas, University of Zaragosa, Spain),44 and mouse monoclonal
anti-b-actin antibody (42 kD; Sigma; 1:5000) either for 2 h at room
temperature or overnight at 4 1C. Membranes were then incubated
for 1 h at room temperature with secondary goat anti-rabbit or
donkey anti-mouse antibodies (1:5000) linked to alkaline phospha-
tase (Promega, Madison, WI) or HRP (Amersham, Freiburg,
Germany). The protein signal was detected with the appropriate
substrates (Millipore) using the DIANA III-chemiluminescence
detection system (Raytest, Straubenhardt, Germany). All images
were analyzed using the software Advanced Image Data Analyser
AIDA (Raytest) to calculate the protein of interest/b-actin ratio.
Determination of bone density
For the analysis of bone density, animals were killed and hind legs
were removed and fixed in formalin. The samples were scanned with
a high-resolution microCAT-II (Siemens, Mu¨nchen, Germany)
small-animal-computed tomography scanner using a field of view
of 3.1 3.1 4.8 cm3. The X-ray tube parameters were set at 80 kVp
and 400 mA. The images were acquired with 720 angular projections
(exposure time 1200ms per projection) over 3601 and binned with a
factor of two, yielding a spatial resolution ofB38 mm. The total scan
time was 24min. Reconstructed computed tomography images were
analyzed with the Inveon Research Workplace software (Siemens) by
drawing a standard-sized area around the femur and applying a
region growth routine to segment the trabecular bone structure. For
all samples, the same upper- and lower-density thresholds were
applied comparing the relative numbers of trabecular bone density.
Bone histology
For morphological bone analysis, femurs of sgk3KO and sgk3WTmice
(n¼ 5–6 in each group) were fixed in 4.5% buffered formalin (Roti-
Histofix 4.5%, Roth, Karlsruhe, Germany) for at least 24 h.
Decalcification was performed in EDTA solution at room tempera-
ture for 2–3 days. The decalcified bones were embedded in paraffin
and cut in 2- to 3-mm thick sections and stained with hematoxylin
and eosin.
Statistical analysis
Data are provided as arithmetic means±s.e.m., n represents the
number of independent experiments. All data were tested for
significance using analysis of variance (Figure 1) or paired or
66 Kidney International (2011) 80, 61–67
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unpaired Student’s t-test. Only results with Po0.05 were considered
statistically significant.
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